PTKFY
Price
$19.50
Change
+$0.85 (+4.56%)
Updated
Jul 2 closing price
Capitalization
5.53B
SNPHF
Price
$11.45
Change
+$0.45 (+4.09%)
Updated
Jun 11 closing price
Capitalization
3.26B
Interact to see
Advertisement

PTKFY vs SNPHF

Header iconPTKFY vs SNPHF Comparison
Open Charts PTKFY vs SNPHFBanner chart's image
PT Kalba Farma TBK
Price$19.50
Change+$0.85 (+4.56%)
Volume$153
Capitalization5.53B
Santen Pharmaceutical
Price$11.45
Change+$0.45 (+4.09%)
Volume$1K
Capitalization3.26B
PTKFY vs SNPHF Comparison Chart in %
Loading...
PTKFY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PTKFY vs. SNPHF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTKFY is a StrongBuy and SNPHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (PTKFY: $19.50 vs. SNPHF: $11.45)
Brand notoriety: PTKFY and SNPHF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: PTKFY: 42% vs. SNPHF: 188%
Market capitalization -- PTKFY: $5.53B vs. SNPHF: $3.26B
PTKFY [@Pharmaceuticals: Major] is valued at $5.53B. SNPHF’s [@Pharmaceuticals: Major] market capitalization is $3.26B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTKFY’s FA Score shows that 2 FA rating(s) are green whileSNPHF’s FA Score has 0 green FA rating(s).

  • PTKFY’s FA Score: 2 green, 3 red.
  • SNPHF’s FA Score: 0 green, 5 red.
According to our system of comparison, PTKFY is a better buy in the long-term than SNPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTKFY’s TA Score shows that 4 TA indicator(s) are bullish while SNPHF’s TA Score has 3 bullish TA indicator(s).

  • PTKFY’s TA Score: 4 bullish, 3 bearish.
  • SNPHF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, PTKFY is a better buy in the short-term than SNPHF.

Price Growth

PTKFY (@Pharmaceuticals: Major) experienced а +12.68% price change this week, while SNPHF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.19%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTKFY($5.53B) has a higher market cap than SNPHF($3.26B). PTKFY has higher P/E ratio than SNPHF: PTKFY (30.03) vs SNPHF (15.31). SNPHF YTD gains are higher at: 8.716 vs. PTKFY (-3.660). PTKFY has higher annual earnings (EBITDA): 4.85T vs. SNPHF (17.2B). PTKFY has more cash in the bank: 3.63T vs. SNPHF (62.3B). SNPHF has less debt than PTKFY: SNPHF (40.1B) vs PTKFY (889B). PTKFY has higher revenues than SNPHF: PTKFY (29.79T) vs SNPHF (270B).
PTKFYSNPHFPTKFY / SNPHF
Capitalization5.53B3.26B169%
EBITDA4.85T17.2B28,209%
Gain YTD-3.6608.716-42%
P/E Ratio30.0315.31196%
Revenue29.79T270B11,032%
Total Cash3.63T62.3B5,822%
Total Debt889B40.1B2,217%
FUNDAMENTALS RATINGS
PTKFY vs SNPHF: Fundamental Ratings
PTKFY
SNPHF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
64
Fair valued
PROFIT vs RISK RATING
1..100
92100
SMR RATING
1..100
14100
PRICE GROWTH RATING
1..100
3951
P/E GROWTH RATING
1..100
6987
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTKFY's Valuation (26) in the null industry is somewhat better than the same rating for SNPHF (64). This means that PTKFY’s stock grew somewhat faster than SNPHF’s over the last 12 months.

PTKFY's Profit vs Risk Rating (92) in the null industry is in the same range as SNPHF (100). This means that PTKFY’s stock grew similarly to SNPHF’s over the last 12 months.

PTKFY's SMR Rating (14) in the null industry is significantly better than the same rating for SNPHF (100). This means that PTKFY’s stock grew significantly faster than SNPHF’s over the last 12 months.

PTKFY's Price Growth Rating (39) in the null industry is in the same range as SNPHF (51). This means that PTKFY’s stock grew similarly to SNPHF’s over the last 12 months.

PTKFY's P/E Growth Rating (69) in the null industry is in the same range as SNPHF (87). This means that PTKFY’s stock grew similarly to SNPHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PTKFYSNPHF
RSI
ODDS (%)
Bearish Trend 4 days ago
31%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
27%
Bullish Trend 4 days ago
40%
Momentum
ODDS (%)
Bullish Trend 4 days ago
41%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
40%
Bearish Trend 4 days ago
47%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
24%
Bullish Trend 4 days ago
38%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
21%
Bullish Trend 4 days ago
27%
Advances
ODDS (%)
Bullish Trend 5 days ago
25%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
38%
Bearish Trend 4 days ago
63%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
14%
View a ticker or compare two or three
Interact to see
Advertisement
PTKFY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGCIX129.381.62
+1.27%
Gabelli Growth I
ADSIX23.730.29
+1.24%
American Century Disciplined Growth Inv
VITSX150.041.28
+0.86%
Vanguard Total Stock Market Idx I
LSVVX14.420.08
+0.56%
LSV Conservative Value Equity
BCLPX8.740.01
+0.11%
BlackRock Event Driven Equity Inv C

PTKFY and

Correlation & Price change

A.I.dvisor tells us that PTKFY and SNPHF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTKFY and SNPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTKFY
1D Price
Change %
PTKFY100%
N/A
SNPHF - PTKFY
6%
Poorly correlated
N/A
RHHBF - PTKFY
6%
Poorly correlated
N/A
SNPHY - PTKFY
0%
Poorly correlated
+1.80%
OTSKF - PTKFY
0%
Poorly correlated
N/A
RCDTF - PTKFY
0%
Poorly correlated
N/A
More

SNPHF and

Correlation & Price change

A.I.dvisor tells us that SNPHF and SNPHY have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHF and SNPHY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHF
1D Price
Change %
SNPHF100%
N/A
SNPHY - SNPHF
7%
Poorly correlated
+1.80%
PTKFY - SNPHF
6%
Poorly correlated
N/A
OTSKY - SNPHF
5%
Poorly correlated
-1.50%
RHHVF - SNPHF
3%
Poorly correlated
-2.91%
PTKFF - SNPHF
1%
Poorly correlated
N/A
More